UK Health Secretary Matt Hancock (Photo: Shutterstock)
UK Health Secretary Matt Hancock said he is "increasingly confident" that England is "on track" for the government's roadmap to exit the coronavirus lockdown, local media reported.
His remarks came after a study by Public Health England (PHE) showed promising results for the two main vaccines being used to fight the pandemic in Britain, reports Xinhua news agency.
"I'm increasingly confident we're on track for the roadmap because this data shows the vaccine after two doses works just as effectively, and we all know that the vaccine is our way out of this," Hancock told Sky News on Sunday.
According to the PHE study, which took place between April 5 and May 16, the Pfizer vaccine was 88 per cent effective against symptomatic disease from the India-related variant two weeks after the second dose, compared with 93 per cent effectiveness against the variant identified in Kent.
Meanwhile, the AstraZeneca jab was 60 per cent effective, compared with 66 per cent against the Kent variant over the same period.
However, they were only 33 per cent effective three weeks after the first dose, the PHE report said.
The PHE said it expects to see even higher levels of effectiveness against hospital admissions and deaths.
Hancock described the outcome as "groundbreaking," adding that "getting the second jab is vital".
From May 17 as part of the government's lockdown easing plan, pubs, bars and restaurants in England were permitted to open indoors, while indoor entertainment resumed, including cinemas, museums and children's play areas.
People were also allowed to travel abroad to a number of green-list countries without having to quarantine upon return as the ban on foreign travel has also been lifted.
The government's roadmap is expected to see all legal limits on social contact to be removed on June 21.
In a paper published on May 21, the government's Scientific Advisory Group for Emergencies (SAGE) said coronavirus may continue to evolve for years to come and that "eradication is extremely unlikely".
The experts warn that eventually it is likely "current vaccines will fail to protect against transmission, infection, or even against disease caused by newer variants".
Nearly 37.7 million people, or more than 70 per cent of adults in Britain, have been given the first jab of the coronavirus vaccine, according to the latest official figures.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.